Highlights of the agenda
- Keynote speeches: Insights into current advances in GLP-1 agonists and their impact on obesity therapy.
Panel Discussions: Topics such as "Potential Magnitude of Market & Impact on the Healthcare System", "BioPharma Dealmaking: Building the Pipeline" and "Unmet Needs & NextGen Therapeutics" will be highlighted by industry experts.
- Investor Panel: Evaluating investment opportunities in emerging biotech companies focused on metabolic diseases.
Leipzig's role as a research and innovation centre
"Leipzig has established itself as an important centre for life sciences in recent years. With facilities such as the Fraunhofer Institute for Cell Therapy and Immunology (IZI) and the BioCity Campus, the city offers a first-class infrastructure for research and development. Programmes such as the Medical Forge support start-ups in bringing medical innovations to market faster," says conference initiator Leonard Sachs, explaining the decision to choose the Saxon metropolis as the location for this first conference of its kind in Europe.
The city is home to a large number of research institutes, including three Max Planck Institutes, two Fraunhofer Institutes and several universities, which together are at the forefront of biomedical research. This concentration of expertise and resources makes Leipzig an ideal location for events such as the EBOIF.
Presence and online format for international reach
The European Biopharma Obesity Innovation Forum is a platform for the exchange of knowledge and ideas to combat obesity. It aims to foster collaboration between academia, industry and investors and develop innovative solutions to one of the most pressing health challenges of our time.
The event will take place as a two-day face-to-face conference in Leipzig. It will be supplemented by a virtual continuation on
18 and 19 June to enable international participation.
Further information, the detailed programme and registration can be found at www.sachsforum.com/1eboif-about.html
Media contact
SCHWARZ Financial Communication
Frank Schwarz
+49 611 580 29290
schwarz@schwarzfinancial.com
